- ABOUT QURE CLINIC
Bringing Precision To Blood Disease And Cancer Care.
- Home
- About Us
- HOW WE BEGAN
Focused on Blood Care. Grounded in Patient Trust.
QURE Is One of the Few Physician Groups in Gujarat Caring Exclusively for Adults and Children With Blood Cancers and Blood Disorders.
Our Mission
Our mission is to provide individualized, guideline-based care for adults and children with blood disorders and cancers. We follow NCCN guidelines and Children’s Oncology Group protocols. Our team offers blood disease treatment in Ahmedabad with compassion, clear communication and respect for every family.
Our Vision
Our vision is to offer modern clinical care to patients of all ages, with compassion at its heart. We aim to grow as a dedicated center for blood disorders and cancer treatment in India. We want every patient to feel informed, supported and respected.
- OUR IMPACT IN NUMBERS
Experience Built on Trust
Every number here represents a family who trusted us with their care. Behind each one is careful evaluation, a thoughtful treatment plan and ongoing support from our team.
- OUR METHODOLOGY
The QURE Approach
- Step 1
Prompt Assessment
- Step 2
Guideline-Based Planning
- Step 3
Treatment and Transplant
- Step 4
Team-Based Outpatient Care
- most patients experience noticeable improvement within the first few sessions.
- WHAT WE STAND FOR
Our Core Values
The principles that guide our decisions, from the first consultation through ongoing care.
Patient-First Thinking
Clinical Accuracy
Honest Communication
Continuous Learning
- Our Doctors
Meet Our Expert Physicians
Dr. Urmish H. Chudgar
MBBS, MD, American Board Certified Hematologist and Oncologist
Founder & Chief Hematologist-Oncologist
US-board-certified specialist with three decades of experience treating complex pediatric and adult blood cancers.
Dr. Eva Bhagat
MBBS, MD, D.Ped
Pediatric Hematologist
Dr. Ankit Raiyani
MBBS, MD Short
Consultant Hematologist
Dr. Himal Shah
MBBS, MD, DM
Consultant Hematologist-Oncologist
Super-specialty trained in stem cell transplants and complex blood cancers requiring multi-line therapy.